These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 2161245)

  • 1. Magnetic resonance imaging of the liver.
    Vassiliades VC; Bernardino ME
    Top Magn Reson Imaging; 1990 Jun; 2(3):1-16. PubMed ID: 2161245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CT Scan and MRI in the Differentiation of Liver Tumors.
    Hori M; Murakami T; Kim T; Tomoda K; Nakamura H
    Dig Dis; 2004; 22(1):39-55. PubMed ID: 15292694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI in the evaluation of hepatocellular nodules: role of pulse sequences and contrast agents.
    Ichikawa T
    Intervirology; 2004; 47(3-5):252-70. PubMed ID: 15383734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive lymphoid hyperplasia of the liver: Perinodular enhancement on contrast-enhanced computed tomography and magnetic resonance imaging.
    Sonomura T; Anami S; Takeuchi T; Nakai M; Sahara S; Tanihata H; Sakamoto K; Sato M
    World J Gastroenterol; 2015 Jun; 21(21):6759-63. PubMed ID: 26074715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Liver imagenology advances].
    Stoopen ME
    Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():37-40. PubMed ID: 17471855
    [No Abstract]   [Full Text] [Related]  

  • 6. MR imaging of liver neoplasms.
    Rummeny E; Saini S; Wittenberg J; Compton C; Hahn PF; Mueller PR; Simeone JF; Stark DD; Weissleder R; Dousset MG
    AJR Am J Roentgenol; 1989 Mar; 152(3):493-9. PubMed ID: 2536996
    [No Abstract]   [Full Text] [Related]  

  • 7. [Focal liver processes: additional diagnostic aspects as seen by nuclear magnetic resonance tomography?].
    Börsch G; Uhlenbrock D; Beyer HK; Schmidt G
    Leber Magen Darm; 1986 Jan; 16(1):35-40. PubMed ID: 3007901
    [No Abstract]   [Full Text] [Related]  

  • 8. Imaging of benign and malignant focal liver lesions.
    Martin DR; Semelka RC
    Magn Reson Imaging Clin N Am; 2001 Nov; 9(4):785-802, vi-vii. PubMed ID: 11694438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features.
    Choi JY; Lee JM; Sirlin CB
    Radiology; 2014 Oct; 273(1):30-50. PubMed ID: 25247563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary liver neoplasms: MR imaging with pathologic correlation.
    Powers C; Ros PR; Stoupis C; Johnson WK; Segel KH
    Radiographics; 1994 May; 14(3):459-82. PubMed ID: 8066263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [VIBE with parallel acquisition technique - a novel approach to dynamic contrast-enhanced MR imaging of the liver].
    Dobritz M; Radkow T; Nittka M; Bautz W; Fellner FA
    Rofo; 2002 Jun; 174(6):738-41. PubMed ID: 12063604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR imaging of the liver: techniques and clinical applications.
    Ito K; Mitchell DG; Matsunaga N
    Eur J Radiol; 1999 Oct; 32(1):2-14. PubMed ID: 10580318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging of diffuse liver disease.
    Mortele KJ; Ros PR
    Semin Liver Dis; 2001 May; 21(2):195-212. PubMed ID: 11436572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver neoplasms: diagnostic pitfalls in cross-sectional imaging.
    Ito K; Honjo K; Fujita T; Awaya H; Matsumoto T; Matsunaga N; Higuchi M; Kada T; Mattrey RF
    Radiographics; 1996 Mar; 16(2):273-93. PubMed ID: 8966286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and application of strawberry-like Fe3O4-Au nanoparticles as CT-MR dual-modality contrast agents in accurate detection of the progressive liver disease.
    Zhao HY; Liu S; He J; Pan CC; Li H; Zhou ZY; Ding Y; Huo D; Hu Y
    Biomaterials; 2015 May; 51():194-207. PubMed ID: 25771010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contrast enhanced ultrasound of the liver--state of the art].
    Dietrich CF; Schreiber-Dietrich D; Schuessler G; Ignee A
    Dtsch Med Wochenschr; 2007 Jun; 132(22):1225-31. PubMed ID: 17520509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric liver imaging.
    Siegel MJ
    Semin Liver Dis; 2001 May; 21(2):251-69. PubMed ID: 11436576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
    Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
    Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast agents used in MR imaging of the liver.
    Karabulut N; Elmas N
    Diagn Interv Radiol; 2006 Mar; 12(1):22-30. PubMed ID: 16538580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic imaging of the liver: sonography/CT/MRI--clinical significance].
    Ramadori G; Neubauer K
    Dtsch Med Wochenschr; 2005 Dec; 130 Suppl 5():S201-2. PubMed ID: 16435708
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.